Slocum, Gordon & Co. LLP has filed a Form 13F-HR disclosing its equity securities holdings as of the close of business on September 30, 2026. The filing lists 66 separate positions held by the firm.
The largest position disclosed in the portfolio is Johnson & Johnson, with 10,663,081 shares. Merck & Co. Inc. is the second-largest holding, with 13,323,712 shares. Other significant holdings include ExxonMobil Holdings Corp. (10,477,340 shares), NextEra Energy Inc. (7,508,746 shares), and Pfizer Inc. (2,510,074 shares).
The filing also lists substantial positions in exchange-traded funds, including the iShares Inc. MSCI Australia ETF (11,629,7 shares), the iShares Inc. MSCI Japan ETF (31,234 shares), and the iShares Inc. TIPS Bond ETF (34,772 shares). Additionally, the firm holds shares in major corporations such as Apple Inc., Microsoft Corp., Procter & Gamble Co., and United Parcel Service Inc.
The report indicates that all positions are held as sole voting power and sole dispositive power.
